London, October 26, 2020 – Collaborative Community Against Coronavirus C.I.C., a not-for-profit collaborative dedicated to ensuring that the worldwide community is better prepared for the epidemics caused by viruses, today announced that recent screening of the 3C chemical library had identified further compounds active against SARS-CoV-2, all based on our goal of identifying inhibitors of viral replication.
These compounds are distinct from our lead series and work is on-going to confirm activity across other coronavirus family members. More details to follow.
For media, investor & collaborator enquiries, please contact: Collaborative Community Against Coronavirus C.I.C.
Dr Eddy Littler & Dr Richard Angell